| 000 | 01414 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513062325.0 | ||
| 264 | 0 | _c19940418 | |
| 008 | 199404s 0 0 eng d | ||
| 022 | _a0300-5127 | ||
| 024 | 7 |
_a10.1042/bst021402s _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarding, E A | |
| 245 | 0 | 0 |
_aBlockade of K+ channels in insulin-secreting cells by the 'potassium channel opener' SDZ PCO 400. _h[electronic resource] |
| 260 |
_bBiochemical Society transactions _cNov 1993 |
||
| 300 |
_a402S p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzopyrans _xpharmacology |
| 650 | 0 | 4 |
_aCell Membrane _xdrug effects |
| 650 | 0 | 4 |
_aCyclopentanes _xpharmacology |
| 650 | 0 | 4 |
_aDiazoxide _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInsulin _xmetabolism |
| 650 | 0 | 4 | _aInsulin Secretion |
| 650 | 0 | 4 |
_aIslets of Langerhans _xdrug effects |
| 650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
| 650 | 0 | 4 |
_aPhentolamine _xpharmacology |
| 650 | 0 | 4 | _aPotassium Channel Blockers |
| 650 | 0 | 4 |
_aPotassium Channels _xphysiology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aTolbutamide _xpharmacology |
| 700 | 1 | _aFinch, A | |
| 700 | 1 | _aDunne, M J | |
| 773 | 0 |
_tBiochemical Society transactions _gvol. 21 _gno. 4 _gp. 402S |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1042/bst021402s _zAvailable from publisher's website |
| 999 |
_c8131302 _d8131302 |
||